The staurosporine-like compound L-753,000 (NB-506) potentiates the neurotrophic effects of neurotrophin-3 by acting selectively at the TrkA receptor

Molecular Pharmacology

Volumn 56, Issue 1, 1999, Pages 185-195

  Pollack, Scott ^a   Young, Lisa ^a   Bilsland, James ^a   Wilkie, Neil ^a   Ellis, Semantha ^a   Hefti, Franz ^a   Broughton, Howard ^a   Harper, Sarah ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

6 FORMYLAMINO 12,13 DIHYDRO 1,11 DIHYDROXY 5H INDOLO[2,3 A][PYRROLO[3,4 C]CARBAZOLE 5,7(6H) DIONE 13 GLUCOSIDE; K 252B; NERVE GROWTH FACTOR RECEPTOR; NEUROTROPHIN 3; PROTEIN KINASE INHIBITOR; STAUROSPORINE; TYROSINE KINASE RECEPTOR;

ANIMAL CELL; ARTICLE; DRUG ACTIVITY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME INHIBITION; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR INTRINSIC ACTIVITY;

EID: 0033057286     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.56.1.185     Document Type: Article

References (35)

1. Arakawa H, Iguchi T, Morita M, Yoshinari T, Kojiri K, Suda H, Okura A and Nishimura S (1995) Novel indolocarbazole compound 6-N-formylamino-12, 13-dihydro-1, 11-dihydroxy-13-(β-D-glucopyranosyl)-5H-indolo [2,3-α] pyrrolo [3,4-c]carbazole-5,7(6H)-dione (NB-506): Its potent antitumor activities in mice. Cancer Res 55:1316-1320.
2. Barbacid M (1994) The Trk family of neurotrophin receptors. J Neurobiol 25:1386-1403.
3. Barde Y-A (1998) Biological roles of neurotrophins, in Neurotrophic Factors: Handbook of Experimental Pharmacology (Hefti F ed) vol 134, pp 1-21, Springer, Berlin.
4. Benedetti M, Levi A and Chao MV (1993) Differential expression of nerve growth factor receptors leads to altered binding affinity and neurotrophin responsiveness. Proc Natl Acad Sci USA 90:7859-7863.
5. Berg MM, Sternberg DW, Parada LF and Chao MV (1992) K-252a inhibits nerve growth factor-induced Trk proto-oncogene tyrosine phosphorylation and kinase activity. J Biol Chem 267:13-16.
6. Bilsland JG, Rigby M, Young L and Harper SJ (1999) A rapid method for semi-quantitative analysis of neunte outgrowth from primary cultures of chick DRG expiants using image analysis. J Neurosci Methods, in press.
7. Borasio GD (1990) Differential effects of the protein kinase inhibitor K-252a on the in vitro survival of chick embryonic neurons. Neurosci Lett 108:207-212.
8. Bottenstein JE and Sato GH (1979) Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc Natl Acad Sci USA 76:514-517.
9. Chao MV and Hempstead BL (1995) p75 and Trk: A two-receptor system. Trends Neurosci 18:321-326.
10. Connor B and Dragunow M (1998) The role of neuronal growth factors in neurode-generative disorders of the human brain. Brain Res Rev 27:1-39.
11. Cowley S, Paterson H, Kemp P, Marshall CJ (1984) Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77:841-852.
12. Greene LA and Kaplan DR (1995) Early events in neurotrophin signalling via Trk and p75 receptors. Curr Opin Neurobiol 5:579-587.
13. Holden PH, Asopa V, Robertson AGS, Clarke AR, Tyler S, Bennett GS, Brain SD, Wilcock GK, Allen SJ, Smith SKF and Dawbarn D (1997) Immunoglobulin-like domains define the nerve growth factor binding site of the TrkA receptor. Nature Biotechnol 15:668-672.
14. Isono F, Widmer HR, Hefti F and Knüsel B (1994) EGF induces PC12 cell differentiation in the presence of the protein kinase inhibitor K-252a. J Neurochem 63:1235-1245.
15. Kaplan DR (1998) Studying signal transduction in neuronal cells: The Trk/NGF system. Prog Brain Res 117:35-46.
16. Kaplan DR, Hempstead BL, Martinzanca D, Chao MV and Parada LF (1991) The trk protooncogene product-a signal transducing receptor for nerve growth factor. Science (Wash DC) 252:554-558.
17. Knüsel B and Hefti FF (1992) K-252 compounds: Modulators of neurotrophin signal transduction. J Neurochem 59:1987-1996.
18. Knüsel B, Kaplan DR, Winslow JW, Rosenthal A, Burton LE, Beck KD, Rabin S, Nikolics K and Hefti F (1992) K-252b selectively potentiates cellular actions and trk tyrosine phosphorylation mediated by NT-3. J Neurochem 59:715-722.
19. Koizumi S, Contreras ML, Matsuda Y, Hama T, Lazarovici P and Guroff G (1988) K-252a: A specific inhibitor of the action of nerve growth factor on PC12 cells. J Neurosci 8:715-721.
20. Lee K-F, Davies AM and Jaenisch R (1994) p75 deficient embryonic dorsal root sensory and neunatal sympathetic neurons display a decreased sensitivity to NGF. Development 120:1027-1033.
21. Maroney AC, Lipfert L, Forbes ME, Glicksman MA, Neff NT, Siman R, Dionne CA (1995) K-252a induces tyrosine phosphorylation of the focal adhesion kinase and neurite outgrowth in human neuroblastoma SH-SY5Y cells. J Neurochem 64:540-549.
22. NTR. J Neurochem 68:88-94.
23. Matsuda Y and Fukuda J (1988) Inhibition by K-252a, a new inhibitor of protein kinase, of nerve growth factor-induced neurite outgrowth of chick embryo dorsal root ganglion cells. Neurosci Lett 87:295-301.
24. McMahon SB and Priestly JV (1995) Peripheral neuropathies and neurotrophic factors: Animal models and clinical perspectives. Curr Opin Neurobiol 5:616-624.
25. Ninkina N, Grashchuck M, Buchman VL and Davies AM (1997) TrkB variants with deletions in the leucine-rich motifs of the extracellular domain. J Biol Chem 272:13019-13025.
26. Nye SH, Squinto SP, Glass DJ, Stitt TN, Hantzopoulos P, Macchi MJ, Lindsay NS, Ip NY and Yancopoulos GD (1992) K-252a and staurosporine selectively block autophosphorylation of neurotrophin receptors and neurotrophin-mediated responses. Mol Biol Cell 3:677-686.
27. Ohmichi M and Decker SJ (1992) Inhibition of the cellular actions of nerve growth factor by staurosporine and K-252a results from the attenuation of the activity of the Trk tyrosine kinase. Biochemistry 31:4034-4039.
28. Rask CA and Escandon E (1998) Neurotrophin treatment of peripheral sensory neuropathies, in Neurotrophic Factors: Handbook of Experimental Pharmacology (Hefti F ed) vol 134, pp 53-72, Springer, Berlin.
29. Swain C, Harper S, Pollack S, Smith R and Hefti F (1998) Neurotrophic factor mimetics, in Neurotrophic Factors: Handbook of Experimental Pharmacology (Hefti F ed) vol 134, pp 281-300, Springer, Berlin.
30. Urfer R, Tsoulfas P, O'Connell L, Shelton, DL, Parada, LF and Presta LG (1995) An immunoglobulin-like domain determines the specificity of neurotrophin receptors. EMBO J 14:2795-2805.
31. Urfer R, Tsoulfas P, O'Connell L, Hongo J-A, Zhao W and Presta LG (1998) High resolution mapping of the binding site of TrkA for nerve growth factor and TrkC for neurotrophin-3 on the second immunoglobulin-like domain of the Trk receptors. J Biol Chem 273:5829-5840.
32. Windisch JM, Auer B, Marksteiner R, Lang ME and Schneider R (1995a) Specific neurotrophin binding to leucine-rich motif peptides of TrkA and TrkB. FEBS Lett 374:125-129.
33. Windisch JM, Marksteiner R and Schneider R (1995b) Nerve growth factor binding site on TrkA mapped to a single 24-amino acid leucine-rich motif. J Biol Chem 1995:28133-28138.
34. Wu C-F and Zhang M (1993) K-252a potentiates epidermal growth factor-induced differentiation of PC12 cells. J Neurosci Res 36:539-550.
35. Yoshinari T, Matsumoto M, Arakawa H, Okada H, Noguchi K, Suda H, Okura A and Nishimura S (1995) Novel antitumor indolocarbazole compound 6-N-formylamino-12, 13-dihydro-1, 11-dihydroxy-13-(β-D-glucopyranosyl)-5H-indolo[2,3-α]pyrrolo[3,4-c] carbazole-5,7(6H)-dione (NB-506): Induction of toppisomerase I-mediated DNA cleavage and mechanisms of cell line-selective cytotoxicity. Cancer Res 55:1310-1315.